Cleared Traditional

K221961 - HydroMARK Plus Breast Biopsy Site Marker (FDA 510(k) Clearance)

Jul 2023
Decision
373d
Days
Class 2
Risk

K221961 is an FDA 510(k) clearance for the HydroMARK Plus Breast Biopsy Site Marker. This device is classified as a Marker, Radiographic, Implantable (Class II - Special Controls, product code NEU).

Submitted by Devicor Medical Products, Inc. (Cincinnati, US). The FDA issued a Cleared decision on July 13, 2023, 373 days after receiving the submission on July 5, 2022.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4300.

Submission Details

510(k) Number K221961 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 05, 2022
Decision Date July 13, 2023
Days to Decision 373 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code NEU — Marker, Radiographic, Implantable
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4300